Please enable js

Safety and
side effects.

safetykit safetykit

What are the possible side effects of Prevnar 20?

What are the possible side effects of Prevnar 20?

For adults, the most common side effects reported in clinical trials were pain at the injection site, muscle pain, fatigue, headache, and joint pain. For adults under 60 years of age, swelling at the injection site was also common.

If you have any questions about the safety information, or want more details, talk to your doctor or pharmacist.

femaledoctor femaledoctor

What should I ask my doctor or pharmacist about Prevnar 20?

Ask if Prevnar 20 can help protect you from pneumococcal pneumonia. Have a conversation with your doctor or pharmacist to see if it’s right for you.

Check out our doctor discussion guide

Prevnar 20 should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 20 or to any diphtheria toxoid.

Adults with weakened immune systems may have a lower response to Prevnar 20. Safety data are not available for these groups. Your healthcare provider can tell you if Prevnar 20 is right for you.

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

  • Prevnar 20TM (Pneumococcal 20-valent Conjugate Vaccine) should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 20 or to diphtheria toxoid
  • Adults with weakened immune systems may have a lower response to Prevnar 20. Safety data are not available for these groups. Your healthcare provider can tell you if Prevnar 20 is right for you
  • In adults 18 years of age and older, the most common side effects (>10%) were pain at the injection site, muscle pain, fatigue, headache, and joint pain. Additionally, injection site swelling was also common in adults 18 through 59 years of age
  • Ask your healthcare provider about the risks and benefits of Prevnar 20. Only a healthcare provider can decide if Prevnar 20 is right for you

Please click here for Prevnar 20 Full Prescribing Information.

INDICATION FOR PREVNAR 20

  • Prevnar 20 is a vaccine indicated for active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in adults 18 years of age and older
  • The indication for preventing pneumonia caused by S. pneumoniae serotypes 8, 10A, 11A, 12F, 15B, 22F, and 33F is approved based on immune responses. Continued approval may depend on a supportive study

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1‐800‐822‐7967.

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

  • Prevnar 20TM (Pneumococcal 20-valent Conjugate Vaccine) should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 20 or to diphtheria toxoid
  • Adults with weakened immune systems may have a lower response to Prevnar 20. Safety data are not available for these groups. Your healthcare provider can tell you if Prevnar 20 is right for you
  • In adults 18 years of age and older, the most common side effects (>10%) were pain at the injection site, muscle pain, fatigue, and headache
  • Ask your healthcare provider about the risks and benefits of Prevnar 20. Only a healthcare provider can decide if Prevnar 20 is right for you

Please click here for Prevnar 20 Full Prescribing Information.

INDICATION FOR PREVNAR 20

  • Prevnar 20 is a vaccine indicated for active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in adults 18 years of age and older
  • The indication for preventing pneumonia caused by S. pneumoniae serotypes 8, 10A, 11A, 12F, 15B, 22F, and 33F is approved based on immune responses. Continued approval may depend on a supportive study
  • Prevnar 20TM is not 100% effective and will only help protect against the 20 strains included in the vaccine

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1‐800‐822‐7967.